Case Studies

Our case studies showcase the breadth of innovative ideas to tangible solutions in agri-food, health, nutrition and the environment at Norwich Research Park.

Alora

Alora arrived at Norwich Research Park in February 2024, from Canada, after going through the IndieBio biotech accelerator programme in San Francisco, California, where it had benefited from a funded development programme.

Ikarovec

Ikarovec is a biotechnology company that is advancing gene therapy to combat the most common eye diseases, including age-related macular degeneration (AMD). Established in 2020, Ikarovec is a spin-in to Norwich Research Park from Cambridge.

TraitSeq

TraitSeq is a spinout from the Earlham Institute. Founded in 2023, it is using AI and machine learning to identify and tackle core agricultural challenges.

iBoxit

iBoxit is tackling the environmental impact of expanded polystyrene with an initial focus on the fish transportation industry. It was founded as a collaboration between entrepreneur John Farley and the University of East Anglia (UEA), in 2016.

Tropic Biosicences

Tropic is a pioneering tropical seeds agri-biotech company that joined Norwich Research Park in 2017.

Grindeks Kalceks UK

Grindeks Kalceks UK, moved to Norwich Research Park in January 2024, having previously been a virtual tenant. It supplies active pharmaceutical ingredients and prescription medicines to over 100 countries. In the UK it works with the NHS, private healthcare and third-party distributors.

Colorifix

Colorifix, founded by two Cambridge scientists in 2016, joined Norwich Research Park in 2018. It has seen rapid growth over the last few years.

Inspiralis

Inspiralis is a spinout from the John Innes Centre that supplies a type of enzyme known as topoisomerases, in the form of easy-to-use kits, to the pharmaceutical industry and academia to aid research into anti-infectives and anti-cancer drugs, specifically when dealing with DNA.

Virilitas

Virilitas is a medtech spinout from the University of East Anglia’s (UEA) School of Biology. It is at the forefront of revolutionising the human fertility industry.

Cellexcel

Cellexcel is a spinout from the University of East Anglia (UEA). Formed in 2021, Cellexcel is at the forefront of sustainable material innovation, poised to revolutionise the paper and packaging industry.

Partner Testimonials

Prof Ian Clark, Professor of Musculoskeletal Biology at UEA, who is leading HealthUEA, said, “We are in a very fortunate position of having such esteemed research partners at Norwich Research Park, who naturally tend to work in a collaborative way. The Norfolk and Norwich University Hospital, Quadram Institute, Earlham Institute, John Innes Centre and The Sainsbury Laboratory are all on the university’s doorstep which is an extremely unusual and immensely beneficial situation to be in. That doesn’t necessarily mean that researchers across the whole Park are aware of everything that each other is doing. HealthUEA will do its best to help bring research partners together, where this can bring additional benefits on top of the individual outcomes.”

Investor Testimonials

Dr Jason Mellad, CEO and Co-founder of Start Codon, said, “Norwich Research Park should double-down on what makes it unique, which is agritech, biotech and health & wellness, where there is a high level of potential.”

Dr Alsheikh-Ali, deputy director-general of the Dubai Health Authority, said, “There is an immense concentration of talented scientists and researchers at Norwich Research Park. Meeting these world-leading thinkers, all of whom are tackling the biggest medical and technical challenges facing humanity, has inspired us to pursue an even deeper level of partnership with the UK and the region.”